ERICA GUILLERMO: Open Payments
NPI 1417190992 · HOUMA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,257 in 68 payments from 16 companies in 2025. Trend: 2023 $1,028 · 2024 $1,458 · 2025 $1,257
Food & beverage: $1,185Education: $72
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $215 |
| ABBVIE INC. | 22 | $189 |
| Organon LLC | 4 | $159 |
| Lilly USA, LLC | 6 | $117 |
| Incyte Corporation | 4 | $89 |
| PFIZER INC. | 3 | $73 |
| Amgen Inc. | 3 | $70 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| GENZYME CORPORATION | 3 | $56 |
| UCB, Inc. | 2 | $52 |
Products named: TREMFYA, RINVOQ, DUPIXENT, TALTZ, OPZELURA, CIBINQO, OTEZLA, SKYRIZI.
Industry payments across LA — which companies pay providers there.
